Newsroom > Ethypharm is the first European pharmaceutical laboratory to be awarded the LUCIE 26000 label for its CSR commitment.

Thursday 16 December 2021 - 15h30

Ethypharm is the first European pharmaceutical laboratory to be awarded the LUCIE 26000 label for its CSR commitment.

Saint-Cloud, France - December 16, 2021 - Ethypharm, a European pharmaceutical company specialising in the fields of the Central Nervous System and Injectable Hospital Drugs, announces that it has obtained the LUCIE 26000 label and joins Europe's leading committed and responsible community. A first for a pharmaceutical company. This certification initially concerns Ethypharm's main European subsidiaries: United Kingdom, France and Germany. 
This certification reflects Ethypharm's commitment to a CSR approach that is fully integrated into its development and respects all its stakeholders.
 
A first in the Pharmaceutical Industry and at European level
 
Ethypharm is the first pharmaceutical laboratory to be awarded the LUCIE label. For the first time, the LUCIE Agency has extended the labelling process beyond France by including Ethypharm's two other European subsidiaries, Germany and the United Kingdom. The Group's other subsidiaries will enter the certification process at a later date.
 
"Through Ethypharm's certification, LUCIE is conquering Europe with the ambition of becoming the reference CSR certification agency by 2030. We are proud to take this next step, while contributing to Ethypharm's CSR commitment”. Said Saliha MARIET, Director of Operations of the LUCIE Agency.
 
Ethypharm's ambition: to improve the company's practices at all levels
 
With the LUCIE label, Ethypharm is committed to strengthening its social and environmental actions with the following objectives: to act on its core business, to involve its employees more and more concretely, to strengthen the dialogue with its external stakeholders and to make its CSR impact more visible in all its actions.
 
This deep commitment is aligned with 7 themes:
 
  • Governance of the organisation
  • Human rights
  • Labour relations and working conditions
  • Environmental issues
  • Good business practice
  • Patient/user issues 
  • Communities and local development
 
"This cross-disciplinary project was supported by a multidisciplinary team. It is fully in line with Ethypharm's development strategy in Europe and internationally. We have placed corporate social responsibility at the heart of our governance. With the LUCIE label, we seek to inspire and encourage Ethypharm's teams to go even further in their environmental, human and social commitments. Obtaining the label from an independent body is part of our desire to build a solid and sustainable company to provide innovative and appropriate solutions to patients", said Daniela Schulte, Chief Human Resources & CSR Officer.  
 
An external audit was carried out by the independent certification body Bureau Veritas Certification and then, after examining the report and the commitments made by Ethypharm to progress over the next three years, an independent labelling committee awarded the LUCIE label.  
 
CSR commitment at the heart of Ethypharm's activities:
 

- A more impactful and collaborative approach close to Ethypharm's teams. Local teams are mobilised to strengthen and enhance their local roots through local initiatives. 
 
- A more responsible approach with, in particular, a sustainable commitment to the Group's responsible purchasing, to reducing our greenhouse gas emissions and to taking account of inclusion in talent management. 
 
- A more visible approach by communicating our mission, progress and results to all our stakeholders. 
 
About Ethypharm  
Ethypharm is a European pharmaceutical company focused on two areas: the Central Nervous System and Hospital injectables. Ethypharm markets its drugs directly in Europe and China, and with partners in North America and the Middle East where its drugs are in high demand. The Group employs 1,500 people, mainly in Europe and China.
Ethypharm works closely with authorities and healthcare professionals to ensure the appropriate use of, and access to,  its medicines by as many people as possible.

For more information about Ethypharm, visit www.ethypharm.com and follow us on LinkedIn.

Media contact 

Avril PONNELLE - Group Communication Manager - +33 1 4112 1720 - presse@ethypharm.com  
 
About the LUCIE Agency
Created in 2007, the LUCIE 26000 label rewards an organisation's commitment to social responsibility according to the guidelines of the ISO 26000 standard. The LUCIE Agency is also developing various solutions to enable all organisations to become more committed and responsible through thematic labels such as ENVOL, the Responsible Digital label or Biodiversity Progress. The LUCIE Community now brings together more than 950 organisations that share the same values and the same desire: to make the world fairer and more respectful of people and territories. Our mission: to give organisations the means to become actors with a positive impact.